Cart

0

Stocks

“These 2 “Strong Buy” Penny Stocks Could Go Boom, Says Roth Capital”

“Cellectar Biosciences (CLRB)… Are other analysts in agreement? They are. 5 Buys and no Holds or Sells have been issued in the last three months. So, the message is clear: CLRB is a Strong Buy. Given the $5.48 average price… Continue Reading…

Stocks

“Raymond James Says These 3 Stocks Could Surge Over 100% From Current Levels”

“Catalyst Biosciences (CBIO)… Other analysts don’t beg to differ. With 3 Buy ratings and no Holds or Sells, the word on the Street is that CBIO is a Strong Buy. At $19.33, the average price target implies 303% upside potential… Continue Reading…